1. Universidade Federal do Rio Grande do Norte
  2. Centro de Biociências
  3. DBF - Departamento de Biofísica e Farmacologia
  4. CB - DBF - Artigos publicados em periódicos
Please use this identifier to cite or link to this item: https://repositorio.ufrn.br/handle/123456789/25422
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAraujo, Aurigena Antunes de-
dc.contributor.authorGuerra, Gerlane Bernardo Coelho-
dc.contributor.authorSolon, Lílian Grace da Silva-
dc.contributor.authorDibildox, Estela-
dc.contributor.authorPerez-Urizar, Jose-
dc.contributor.authorEscobedo-Moratilla, Abraham-
dc.contributor.authorTorres-Roque, Irma-
dc.contributor.authorMartinez-Delgado, Maricela-
dc.contributor.authorZapata-Morales, Juan Ramon-
dc.contributor.authorSoares, Luiz Alberto Lira-
dc.contributor.authorCovarrubias-Pinedo, Amador-
dc.date.accessioned2018-06-16T11:51:25Z-
dc.date.available2018-06-16T11:51:25Z-
dc.date.issued2014-03-04-
dc.identifier.citationARAÚJO, Aurigena Antunes de et al. Comparative Bioavailability of Two Extemporaneous Solid Formulations of Carbamazepine against the Innovator in Mexican Healthy Subjects. Journal of Bioequivalence & Bioavailability, v. 6, p. 033-037, 2014. Disponível em: <https://www.omicsonline.org/open-access/comparative-bioavailability-of-two-extemporaneous-solid-formulations-of-carbamazepine-against-the-innovator-in-mexican-healthy-subjects-jbb.1000177.php?aid=25060>. Acesso em: 19 mar. 2018.pt_BR
dc.identifier.issn0975-0851-
dc.identifier.urihttps://repositorio.ufrn.br/jspui/handle/123456789/25422-
dc.languageengpt_BR
dc.publisherOMICS Internationalpt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectCarbamazepinept_BR
dc.subjectPharmacokineticspt_BR
dc.subjectAnti-epilepticspt_BR
dc.subjectHPLCpt_BR
dc.subjectBioavailabilitypt_BR
dc.subjectBioequivalencept_BR
dc.titleComparative Bioavailability of Two Extemporaneous Solid Formulations of Carbamazepine against the Innovator in Mexican Healthy Subjectspt_BR
dc.typearticlept_BR
dc.identifier.doihttp://dx.doi.org/10.4172/jbb.1000177-
dc.description.resumoExtemporaneous or off-label prescribing is not illegal and may sometimes be clinically and economically appropriate. However it is associated with a number of clinical, safety and ethical issues. Bioequivalence of these products must be proven before they are used in place of patent medicines. In the present study, a single-center, open, randomized, single-dose, 2-period crossover, 2-sequences pilot assay (two subgroups with n=6) was carried out to evaluate the bioavailability of two extemporaneous capsule of carbamazepine (200 mg): A-Formula® (A); and Formule® (B) in comparison to a tablet of the innovator product Tegretol® (C). Twelve healthy volunteers were randomly assigned to one of two arms to receive one test/reference formulation and following a two week wash-out period they received the other compound. Blood sampling was performed over 72 hours after dosing and levels of carbamazepine were determined by HPLC. Main findings of the study include that peak of plasma carbamazepine was faster following the extemporaneous capsules as compared to reference (Tmax: A: 6.58 h; B: 4.83 h vs 8.25-10.00 h, respectively), although no changes was observed in Cmax (A: 3.32 μg/mL; B: 3.10 μg/mL vs C: 3.14-2.85 μg/mL) neither in AUC0-t (A: 116.34 μg*h/mL; B: 145.66 μg*h/mL vs C: 123.18-138.37 μg*h/mL). The elimination half-life that ranged between 38.64-61.29 h but not difference were observed between all formulations. By using bioequivalence statistics it appears that A-Formula® or Formule® is bioequivalent to Tegretol® in terms of AUC0-t but not regarding Cmax. In conclusion, we demonstrated that two extemporaneous capsules of carbamazepine, A-Formula® and Formule® show similar concentration-time profiles to the reference tablet of immediate Tegretol®, however further studies with longer sample size are needed to confirm its bioequivalence and interchangeability.pt_BR
Appears in Collections:CB - DBF - Artigos publicados em periódicos

Files in This Item:
File Description SizeFormat 
ComparativeBioavailabilityExtemporaneous_Araujo_2014.pdf982.16 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.